I. Hajdú

E. Berényi, G. Nagy, I. Hajdú, 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

In Vivo Imaging of Neo-angiogenesis of Transplanted Metastases in Subrenal Capsule Assay Induced Rat Model

I. Hajdú, M. Emri, G. Mező, 2022, In Vivo.

Monoclonal antibody proteomics: use of antibody mimotope displaying phages and the relevant synthetic peptides for mAb scouting.

I. Hajdú, B. Flachner, Z. Lorincz, 2014, Immunology letters.

Postprandial hyperinsulinemia in patients with mild essential hypertension.

I. Hajdú, M. Weiss, P. Singer, 1985, Hypertension.

Ligand-induced conformational rearrangements regulate the switch between membrane-proximal and distal functions of Rho kinase 2

A. Szilágyi, P. Gál, P. Závodszky, 2020, Communications biology.

Rapid in silico selection of an MCHR1 antagonists’ focused library from multi-million compounds’ repositories: biological evaluation

I. Hajdú, B. Flachner, Z. Lorincz, 2014, Medicinal Chemistry Research.

Combined nano-membrane technology for removal of lead ions

I. Hajdú, L. Daroczi, J. Tamás, 2012 .

Robust Recombinant Expression of Human Placental Ribonuclease Inhibitor in Insect Cells

I. Hajdú, B. Flachner, Z. Lorincz, 2022, Biomolecules.

Folate receptor targeted self-assembled chitosan-based nanoparticles for SPECT/CT imaging: demonstrating a preclinical proof of concept.

I. Hajdú, L. Balogh, A. Polyák, 2014, International journal of pharmaceutics.

(99m)Tc-labelled nanosystem as tumour imaging agent for SPECT and SPECT/CT modalities.

I. Hajdú, G. Jánoki, L. Balogh, 2013, International journal of pharmaceutics.

Inhibition of the LOX enzyme family members with old and new ligands. Selectivity analysis revisited.

I. Hajdú, J. Kardos, Z. Lorincz, 2018, Bioorganic & medicinal chemistry letters.

Lipid and blood pressure-lowering effect of mackerel diet in man.

I. Hajdú, W. Jaeger, M. Wirth, 1983, Atherosclerosis.

111In-Labeled Glycoprotein Nonmetastatic b (GPNMB) Targeted Gemini Surfactant-Based Nanoparticles against Melanoma: In Vitro Characterization and in Vivo Evaluation in Melanoma Mouse Xenograft Model.

I. Hajdú, I. Badea, H. Fonge, 2019, Molecular pharmaceutics.

Identification of potential glutaminyl cyclase inhibitors from lead-like libraries by in silico and in vitro fragment-based screening

I. Simon, C. Magyar, I. Hajdú, 2017, Molecular Diversity.

PET Probes for Preclinical Imaging of GRPR-Positive Prostate Cancer: Comparative Preclinical Study of [68Ga]Ga-NODAGA-AMBA and [44Sc]Sc-NODAGA-AMBA

I. Hajdú, G. Opposits, G. Trencsényi, 2022, International journal of molecular sciences.

The structural background of non arrhenius behavior of enzyme reactions – the role of conformational flexibility in the temperature adaptation of proteins

I. Hajdú, 2009 .

In Vivo Assessments of Mesoblastic Nephroma (Ne/De) and Myelomonoblastic Leukaemia (My1/De) Tumour Development in Hypercholesterolemia Rat Models

I. Hajdú, I. Garai, G. Trencsényi, 2022, International journal of molecular sciences.

In Vivo Preclinical Assessment of β-Amyloid–Affine [11C]C-PIB Accumulation in Aluminium-Induced Alzheimer’s Disease-Resembling Hypercholesterinaemic Rat Model

I. Hajdú, G. Trencsényi, I. Kertész, 2022, International journal of molecular sciences.

Some aspects of modeling hydrocarbon oxidation

K. Héberger, I. Hajdú, D. Gál, 1981 .

Rapid in silico selection of an MCHR1 antagonists’ focused library from multi-million compounds’ repositories: biological evaluation

I. Hajdú, B. Flachner, Z. Lorincz, 2014, Medicinal Chemistry Research.

Dual Inhibitors of AChE and BACE-1 for Reducing Aβ in Alzheimer’s Disease: From In Silico to In Vivo

A. Goldblum, I. Hajdú, B. Flachner, 2022, International journal of molecular sciences.

Biopolymer-based nanosystem for ferric ion removal from water

I. Hajdú, J. Tamás, M. Bodnár, 2013 .

Natural Apocarotenoids and Their Synthetic Glycopeptide Conjugates Inhibit SARS-CoV-2 Replication

J. Kos, G. Keserű, J. Hodek, 2021, Pharmaceuticals.

Semisynthetic teicoplanin derivatives with dual antimicrobial activity against SARS-CoV-2 and multiresistant bacteria

L. Naesens, J. Kos, G. Keserű, 2022, Scientific Reports.

Studies on the interaction of peroxy radicals with transition metals complexes

I. Hajdú, T. Szymańska-Buzar, D. Gál, 1987 .

On the induced decomposition of α-phenylethylhydroperoxide by peroxy radicals

I. Hajdú, D. Gál, I. Nemes, 1977 .

Thermal decomposition and autoxidation of cobalt acetylacetonates

I. Hajdú, D. Gál, G. Vasvári, 1974 .

Decomposition of 1-phenylethyl hydroperoxide by methyl(pyridine)-bis(dimethylglyoximato)-cobalt(III)

I. Hajdú, D. Gál, J. Lukács, 1988 .

A versatile modular vector set for optimizing protein expression among bacterial, yeast, insect and mammalian hosts

P. Závodszky, É. Gráczer, T. Szimler, 2019, PloS one.

Tumor-specific localization of self-assembled nanoparticle PET/MR modalities.

G. Banfalvi, I. Hajdú, M. Emri, 2014, Anticancer research.

Matrix Metalloproteinase Inhibitors

P. Ferdinandy, I. Hajdú, S. Cseh, 2010, Drugs.

Rates of unfolding, rather than refolding, determine thermal stabilities of thermophilic, mesophilic, and psychrotrophic 3-isopropylmalate dehydrogenases.

A. Szilágyi, B. Melnik, P. Závodszky, 2007, Biochemistry.

Radiochemical synthesis and preclinical evaluation of 68Ga‐labeled NODAGA‐hydroxypropyl‐beta‐cyclodextrin (68Ga‐NODAGA‐HPBCD)

I. Hajdú, L. Szente, É. Fenyvesi, 2019, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Adjustment of conformational flexibility of glyceraldehyde-3-phosphate dehydrogenase as a means of thermal adaptation and allosteric regulation

A. Szilágyi, P. Gál, P. Závodszky, 2008, European Biophysics Journal.

Substrate-assisted movement of the catalytic Lys 215 during domain closure: site-directed mutagenesis studies of human 3-phosphoglycerate kinase.

Beáta Flachner, Gergely Gyimesi, Péter Závodszky, 2005, Biochemistry.

In vivo preclinical assessment of novel 68Ga-labelled peptides for imaging of tumor associated angiogenesis using positron emission tomography imaging.

I. Hajdú, G. Mező, J. Hunyadi, 2021, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

Insights into recent preclinical studies on labelled cyclodextrin-based imaging probes: towards a novel oncological era.

I. Hajdú, G. Trencsényi, F. Fenyvesi, 2023, International journal of pharmaceutics.

Overview of Prostaglandin E2 (PGE2)-Targeting Radiolabelled Imaging Probes from Preclinical Perspective: Lessons Learned and Road Ahead

I. Hajdú, G. Trencsényi, I. Kertész, 2023, International journal of molecular sciences.

Placental Galectins Are Key Players in Regulating the Maternal Adaptive Immune Response

R. Romero, P. Závodszky, I. Hajdú, 2019, Front. Immunol..

Rapid Identification of Potential Drug Candidates from Multi-Million Compounds’ Repositories. Combination of 2D Similarity Search with 3D Ligand/Structure Based Methods and In Vitro Screening

I. Hajdú, K. Szilágyi, B. Flachner, 2021, Molecules.

Evolution of the concept of conformational dynamics of enzyme functions over half of a century: A personal view.

P. Závodszky, I. Hajdú, 2013, Biopolymers.

In vivo assessment of tumor targeting potential of 68Ga-labelled randomly methylated beta-cyclodextrin (RAMEB) and 2-hydroxypropyl-β-cyclodextrin (HPβCD) using positron emission tomography.

I. Hajdú, G. Opposits, G. Méhes, 2022, International journal of pharmaceutics.